9 Best Articles on Techbio
The most useful articles on techbio from around the web—beginners to advanced—curated by thought leaders and our community. We focus on timeless pieces and update the list whenever we discover new, must-read articles or videos—make sure to bookmark and revisit this page.
Top 5 Techbio Articles
At a glance: these are the articles that have been most read, shared, and saved on techbio by Refind users in 2023 so far.
- Here’s why we’re not prepared for the next wave of biotech innovation
- Inside the billion-dollar meeting for the mega-rich who want to live forever
- A bionic pancreas could solve one of the biggest challenges of diabetes
- Biotech labs are using AI inspired by DALL-E to invent new drugs
- This biotech startup says mice live longer after genetic reprogramming
What is ...?
New to #techbio? These articles make an excellent introduction.
What is TechBio?
Why Cantos invests in engineering-led biology
Short Articles
Short on time? Check out these useful short articles on techbio—all under 10 minutes.
Inside the billion-dollar meeting for the mega-rich who want to live forever
Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.
This biotech startup says mice live longer after genetic reprogramming
The result is a widely anticipated landmark for rejuvenation technology.
Biotech labs are using AI inspired by DALL-E to invent new drugs
Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.
Chroma
Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering.
A bionic pancreas could solve one of the biggest challenges of diabetes
The device uses an algorithm to calculate a meal’s carbohydrates, then automatically releases insulin, taking those burdens off the patient.
Long Articles
These are some of the most-read long-form articles on techbio.
Here’s why we’re not prepared for the next wave of biotech innovation
This is "biology's century," @matthewherper writes. But we’re approaching a moment when changes in what we understand are every bit as terrifying as exhilarating.
Deal or Die: Your 3-Part Guide to Business Development in TechBio
Making deals in TechBio is about forging authentic relationships. That's why today we're releasing our guide to building that network early.
Publications
We monitor hundreds of publications, blogs, newsletters, and news sources in Techbio, including:
MIT Technology Review
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
Notion
The connected workspace for your docs, projects, and knowledge.
Sifted
In-depth reporting on startup Europe, for startup Europe. 🇪🇺 Backed by the FT. Get the latest to your inbox: http://sifted.eu/newsletters
Crunchbase News
Data-driven reporting on private markets, startups, founders, and investors. Send tips to: news@crunchbase.com
STAT
Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: http://statnews.com/signup
What is Refind?
Every day Refind picks the most relevant links from around the web for you. Picking only a handful of links means focusing on what’s relevant and useful. We favor timeless pieces—links with long shelf-lives, articles that are still relevant one month, one year, or even ten years from now. These lists of the best resources on any topic are the result of years of careful curation.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on techbio?
We monitor hundreds of sources on techbio, including MIT Technology Review, Notion, Sifted, Crunchbase News, STAT, and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to hello@refind.com
Who uses Refind?
200k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.